{
  "ticker": "TTX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02963003",
  "id": "02963003",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250627",
  "time": "1453",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250627/pdf/06l5yx5z02w2gw.pdf",
  "summary": "**Summary of ASX Announcement \u2013 Tetratherix Limited (TTX) Admission & Quotation**  \n\n- **IPO Details**:  \n  - Capital raised: **$25M** via issuance of **8,680,000 shares** at **$2.88/share**.  \n  - Total ordinary shares quoted: **26,595,983** (ASX code: **TTX**).  \n\n- **Key Dates**:  \n  - Quotation commences: **30 June 2025 at 11:00 AM AEST**.  \n\n- **Escrowed Securities**:  \n  - **23,570,766 shares** restricted until **30 June 2027** (24-month escrow).  \n  - Smaller tranches (14,059\u201318,951 shares) restricted for **12 months** from respective issuance dates.  \n\n- **Additional**:  \n  - Business focus: **Development/manufacture of patented biomaterials**.  \n  - Underwriters/Joint Lead Managers: **Barrenjoey Markets & Morgans Corporate Limited**.  \n\n*(Omitted: Registry details, contact info, boilerplate.)*",
  "usage": {
    "prompt_tokens": 1092,
    "completion_tokens": 230,
    "total_tokens": 1322,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-27T05:17:44.774741"
}